Mazdutide is a dual agonist of the GLP-1 and glucagon receptors, originally designed to treat type 2 diabetes and obesity. It increases insulin secretion, lowers blood sugar levels, increases energy expenditure, improves fat metabolism in the liver, delays gastric emptying, and causes weight loss. Clinical trials have proven that Mazdutide leads to an average 9.5% weight loss within 12 weeks and 14% average weight loss at 48 weeks.
Mazdutide is considered the safest GLP-1 peptide, and side effects are generally minimal.
Benefits
- Boosts metabolic functions
- Weight loss
- Burns calories more efficiently
- Regulates blood sugar
- Improves lipid levels
- Better cardiovascular health
- Improves blood pressure
- Increases bone health
- Promotes bone formation and inhibits bone breakdown
- Reduces risk of bone fracture and osteoporosis
- Reduces liver fat content
- Reduces liver inflammation
Possible Side Effects
- Injection site reaction (redness, swelling, and/or itching)
- Abdominal distension
- Decreased appetite
- Diarrhea
- Nausea
- Vomiting
Contraindications
Do not take Mazdutide if you are pregnant or nursing.
